Source: FDA, National Drug Code (US) Revision Year: 2019
Ga 68 DOTATOC Injection is a radioactive diagnostic agent for intravenous administration. It contains 3.6 mcg/mL (DOTA-0-Phe1-Tyr3) octreotide, 18.5 MBq/mL to 148 MBq/mL (0.5 mCi to 4 mCi/mL) of Ga 68 DOTATOC at calibration time, and ethanol (10% v/v) in sodium chloride (9 mg/mL) solution (approximately 14 mL volume). Ga 68 DOTATOC Injection is a sterile, pyrogen free, clear, colorless, buffered solution, with a pH between 4 to 8.
Ga 68 DOTATOC, also known as Gallium-68 (DOTA0-Phe1-Tyr3) octreotide, is a cyclic 8 amino acid peptide with a covalently bound chelator (DOTA). The peptide has the amino acid sequence: H-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, and contains one disulfide bond. Ga 68 DOTATOC has a molecular weight of 1489.65 g/mol and its chemical structure is shown in Figure 1.
Figure 1. Chemical Structure of Ga 68 DOTATOC:
Gallium-68 labeled 2-[4-[2-[[(2R)1[[(4R,7S,10S,13R,16S,19R)10(4-aminobutyl)4[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]7[(1R)-1-hydroxyethyl]16[(4-hydroxyphenyl)methyl]13(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid.
Table 3 and Table 4 display the principal radiation emission data and physical decay of Ga 68.
Gallium-68 (Ga 68) decays with a half-life of 68 minutes to stable Zn 68:
Table 3. Principal Radiation Emission Data (>1%):
Radiation/Emission | % Disintegration | Mean Energy (MeV) |
---|---|---|
beta+ | 88% | 0.8360 |
beta+ | 1.1% | 0.3526 |
gamma | 178% | 0.5110 |
gamma | 3% | 1.0770 |
X-ray | 2.8% | 0.0086 |
X-ray | 1.4% | 0.0086 |
Table 4. Physical Decay Chart for Gallium Ga-68:
Minutes | Fraction Remaining |
---|---|
0 | 1.000 |
15 | 0.858 |
30 | 0.736 |
60 | 0.541 |
90 | 0.398 |
120 | 0.293 |
180 | 0.158 |
360 | 0.025 |
Gamma constant: 1.8 × 10-4 mSv/hr per MBq at 1 meter [0.67 mrem/hr per mCi at 1 meter]. Table 5 displays the radiation attenuation by lead shielding of Ga 68.
Table 5. Radiation Attenuation of 511 keV Photons by Lead (Pb) Shielding:
Shield Thickness (Pb) mm | Coefficient of Attenuation |
---|---|
6 | 0.5 |
12 | 0.25 |
17 | 0.1 |
34 | 0.01 |
51 | 0.001 |
Dosage Forms and Strengths |
---|
Injection: Gallium Ga 68 DOTATOC Injection is a clear, colorless solution in a 30 mL multiple-dose vial containing 18.5 MBq/mL to 148 MBq/mL (0.5 mCi/mL to 4 mCi/mL) of Ga 68 DOTATOC Injection at calibration date and time. |
How Supplied |
---|
Ga 68 DOTATOC Injection is supplied in a multiple-dose, capped 30 mL glass vial containing 18.5 MBq/mL to 148 MBq/mL (0.5 mCi/mL to 4 mCi/mL) of Ga 68 DOTATOC at calibration time in approximately 14 mL of solution (NDC 24417-681-30). |
Drug | Countries | |
---|---|---|
Ga-68-DOTATOC | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.